Through nasal inhalation, including a specific group of highly concentrated salts and 100 Mg/dose fluticasone, no other active substances are added; used to treat inflammation or other pathogenic diseases. My respiratory system.

摘要

The present invention is directed to the combination of a muscarinic receptor antagonist and a corticosteroid, and the use of said combination in treating diseases mediated via the M3 muscarinic acetylcholine receptor and/or the glucocorticoid receptor, such as asthma.